开盘价:-- | 最高价:-- | 最低价:-- | 52周最高价:-- | 52周最低价:-- |
成交量:-- | 平均成交量:-- | 市值:-- | 市盈率:-- | 预期市盈率:-- |
每股收益:-- | 贝塔系数:-- | 股息:-- | 收益率:-- | 总股本:-- |
证券代码:alt | 公司名称:Altimmune, Inc. | 公司中文简称: |
公司简介: Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD. |
||
公司网站: http://www.altimmune.com |
||
公司地址: 910 Clopper Road Suite 201S Gaithersburg |